Certain Restricted Stock Units of Arcutis Biotherapeutics, Inc. are subject to a Lock-Up Agreement Ending on 1-JAN-2021. These Restricted Stock Units will be under lockup for 91 days starting from 2-OCT-2020 to 1-JAN-2021. Details: In connection with this offering, the company, and directors, executive officers and certain of stockholders have agreed, subject to certain exceptions, with the underwriters not to dispose of or hedge any shares of common stock or securities convertible into or exchangeable for shares of common stock during the period from the date of the lock-up agreement continuing through the date 90 days following the date of this prospectus, except with the prior written consent of Goldman Sachs & Co. LLC and Cowen and Company, LLC.